wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37329579-0BEA587A-4E92-4E2E-8291-D4DD20DE497E
Q37329579-0BEA587A-4E92-4E2E-8291-D4DD20DE497E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37329579-0BEA587A-4E92-4E2E-8291-D4DD20DE497E
Post-progression survival in patients with non-small cell lung cancer with clinically acquired resistance to gefitinib.
P2860
Q37329579-0BEA587A-4E92-4E2E-8291-D4DD20DE497E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37329579-0BEA587A-4E92-4E2E-8291-D4DD20DE497E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e3928e6d3c76707ee0eb113c5ea5be01938daf10
P2860
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial